From executive leadership moves to new product developments, here are key headlines about orthopedic regenerative medicine from the third quarter:
1. Spiderwort, a startup developing cellulose-based tissue scaffolding to treat acute spinal cord injuries, has secured $13.2 million through a series A financing round
2. NovaBone, a biologic medtech company focused on orthopedic and dental products, hired Brian Carlisle as CEO
3. AlloSource's president and CEO, Tom Cycyota, announced plans to retire after leading the biologics company for 22 years
4. Orthofix and CGBio partnered for the development and commercialization of Novosis, a bone growth material and regenerative products
5. Randal "Randy" Mills, PhD, co-founder of Aziyo Biologics, assumed the role of president and CEO of the company
6. Richard Caruso, PhD, founder, former CEO and former chair of Integra lifeSciences, has died
7. Ortho Regenerative Technologies changed its name to ChitogenX.
8. Ventris Medical's Amplify synthetic bone graft putty earned FDA 510(k) clearance.